Added to YB: 2025-09-23
Pitch date: 2025-09-19
VMED.DE [bullish]
Viromed Medical AG
+77.46%
current return
Author Info
PPinvest is an Ex-Citibanker who shares stock pitches in their newsletter. Sign up for the newsletter.
Company Info
Viromed Medical AG engages in the development and distribution of products in diagnostics, therapeutics, and cold plasma technology.
Market Cap
EUR 145.6M
Pitch Price
EUR 3.86
Price Target
16.60 (+142%)
Dividend
N/A
EV/EBITDA
-481.74
P/E
240.80
EV/Sales
28.54
Sector
Health Care Providers and Services
Category
growth
The Cold Revolution in Medicine - Viromed Medical
VMED.DE: Cold plasma tech pioneer targeting €9.7M 2025 revenue, exploding to €80M+ 2026 on ViroCAP/PulmoPlas launches. Asian partnerships locked (€32.5M 2026, €60M p.a. 2027+). Trading 1.3x EV/Sales 2026, 6.6x P/E with price target of €16.6. High risk/reward small-cap with 66% insider ownership.
Read full article (4 min)